Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05304052 · ClinicalTrials.gov registry record · NA

Mindfulness Meditation Neuroimaging Study for Undergraduates

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
49
Enrollment target

NCT05304052 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 49 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05304052, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
49 participants
Enrollment target

Study Summary

This study is designed to test the effectiveness of mindfulness meditation intervention classes on psychosocial health outcomes. Additionally, the investigators would like to examine changes in the brain that might occur following the mindfulness meditation intervention. The investigators are particularly interested in changes in brain activity that are correlated with changes in inflammation-related markers in the blood. The nervous system and immune system are closely connected, and both are influenced by mindfulness. However, it is unclear whether changes in neural activity are linked with changes in inflammation. A compelling feature of mindfulness interventions is their potential for reducing inflammatory activity; however, this has not been examined in college students. In addition to measuring psychosocial outcomes, the investigators will employ sophisticated, vertically-integrated measures of inflammatory biology that allow the study team to probe intervention effects on circulating markers of inflammation. Thus, the investigators intend to recruit 60 undergraduate students and will randomize them into either a 6-week standardized mindfulness intervention or to a wait-list control group. Participants will complete brain scans, provide blood samples for immune analysis, and complete questionnaires at pre- and post-intervention assessments

Interventions

  • BEHAVIORAL Mindfulness Meditation classes

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2022-03-27
Est. Completion 2023-06-10
Phase NA

What the Registry Record Tells You About NCT05304052

The ClinicalTrials.gov registry entry for NCT05304052 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Mindfulness Meditation classes is the first listed.

NCT05304052 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05304052 about?

NCT05304052 is a clinical study titled "Mindfulness Meditation Neuroimaging Study for Undergraduates". This study is designed to test the effectiveness of mindfulness meditation intervention classes on psychosocial health outcomes. Additionally, the investigators would like to examine changes in the brain that might occur following the mindfulness meditation intervention. The investigators are partic...

What is the current status of trial NCT05304052?

This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2022-03-27. Estimated completion is 2023-06-10.

What interventions are being tested in trial NCT05304052?

The interventions under investigation include: Mindfulness Meditation classes (BEHAVIORAL).

Who is sponsoring clinical trial NCT05304052?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.